Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.05 0.51% 9.90 0.00 16:35:28
Bid Price Offer Price High Price Low Price Open Price
9.70 10.10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 4.85 -2.90 -1.51 17
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 9.90 GBX

Plant Health Care (PHC) Latest News

More Plant Health Care News
Plant Health Care Investors    Plant Health Care Takeover Rumours

Plant Health Care (PHC) Discussions and Chat

Plant Health Care (PHC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Plant Health Care trades in real-time

Plant Health Care (PHC) Top Chat Posts

Plant Health Care Daily Update: Plant Health Care Plc is listed in the Chemicals sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 9.85p.
Plant Health Care Plc has a 4 week average price of 8p and a 12 week average price of 7.70p.
The 1 year high share price is 15.50p while the 1 year low share price is currently 4.28p.
There are currently 172,822,881 shares in issue and the average daily traded volume is 32,244 shares. The market capitalisation of Plant Health Care Plc is £17,109,465.22.
1pencil: Awarding options with a strike price of 1p. "The Company has awarded 6.5m options with an exercise price of 1p per share under the Plan (representing 2.58% of the Company's current issued share capital)"
cerrito: Just caught up with the midweek news from Bayer reducing expectations from their agricultural sciences division for the rest of this year and next because of Covid related issues. I need yo work out the see through to PHC. Any views?
colin12345678: Highlights: US Corn - PHC 279 increased corn yields by 9-15% when applied as a foliar spray, creating potential grower value of $54 - $82 per acre at current average prices. - PHC279 significantly improved the control of two key corn diseases by as much as 50%, even under heavy disease pressure. Spring wheat - PHC279 increased yield by as much as 17% when added to the standard disease control program, which is worth $86 per acre at current prices. Lettuce - PHC279 increased yield by as much as 22% compared to fungicides alone. - PHC279 also improved disease control as much as 31% following foliar application. In the US, 91m acres of corn were planted in 2019. Severe southern rust disease can routinely reduce corn yields as much as 25 bushels per acre. At current prices, this would equate to lost revenue for the farmer of $79 per acre. In historical epidemics of southern corn leaf blight, yields were reduced by 20 to 25 percent nationwide, resulting in an estimated $1 billion loss in harvest. In the Company's trials, when PHC279 was applied together with a leading chemical fungicide, it significantly improved control of both diseases compared to the fungicide treatment alone, and yields were increased by as much as 26 bushels per acre depending on application timing. Even a more modest benefit of 5-10 bushels per acre is likely to provide an attractive return on investment in the potential range of 5:1 to 8:1 for farmers who apply PHC279 to their fields. In the UK, when PHC279 was applied to spring wheat seeds prior to planting, followed by adding it to the standard spray fungicide program, yield was increased by as much as 17% in fields with Septoria tritici blotch, the major disease of wheat in the UK. At current prices, this yield benefit would be worth $86 per acre to the farmer. Lettuce drop disease is a major pathogen affecting US lettuce cultivation. In a series of US field trials inoculated with Sclerotinia, the causative agent of lettuce drop disease, PHC279 treated plants yielded as much as 22% more than plants treated only with the standard chemical fungicide program. With an acre of lettuce worth more than $10,000 in the US in 2018, even a modest increase in lettuce yield will likely justify the cost of applying PHC279. Plant Health Care's PREtec peptides stimulate the plant to defend itself. Derived from natural proteins, this is a novel, environmentally friendly approach to protecting crops and increasing yields, compatible with mainstream agricultural practice. PHC279 may allow farmers to reduce applications of toxic fungicides or to achieve better control of disease. Gary L. Cloud, Ph.D., a research agronomist and owner of GLC Consulting, Inc. participated in the testing of PHC279 in corn this season, and offered the following, "There was heavy disease pressure and PHC279 provided visible improvement in disease control and higher yield compared to the standard fungicide when applied early in the growing season. That is somewhat amazing due to the time that elapsed between application and harvest. I believe PHC279 will be a valuable tool for corn growers struggling to control disease in their fields." Chris Richards, CEO of Plant Health Care, said "We are extremely encouraged with the performance of PHC279 in multiple key crops. Building on our recent success with PHC279 for the control of Asian soybean rust in Brazil, it is clear PHC279 will have important benefits for farmers in many crops. The registration of our first PREtec peptide is progressing in the US and Brazil and the scale-up of manufacturing has started. We are excited about the potential for products based on our PREtec peptides, which are targeting markets with an initial opportunity of $5 billion. We aim to launch the first peptides as soon as regulatory permits have been obtained, to offer these valuable new tools to growers in the US and other countries."
cerrito: I listened to the Edison TV interview with Dr Richards and went through the prelins in a bit more depth. He reiterated what they said in the prelims ie that even in the worst case scenario they had cash till early 2022. Note the March 21 RNS referred to approvals for PHC 279 but I could see no reference to that in the prelims. I need to say that on further reflection I have got confused about how strong sales will be in 2020 given Brazil ethanol and also US fruit industry with both labour issues and disappearance of restaurant trade, A slow burn but at least they have plenty of cash.
cerrito: Interesting that they limited the share raising to an amount which even before expenses was less than 2019 cash burn. Suggests that they have a good deal of confidence, which is manifest in the directors'participation. Typo56 I can understand why you say what you said. However I am sure that you have also seen many occasions when AIM companies have done an Equity raise which has excluded private shareholders and the price has subsequently fallen below the share offer price.
riddlerone: What a disgrace,massive discounted placing again from the management that keep insisting that they are funded until cash flow positive. "The Issue Price represents a discount of approximately 43.9 per cent. to the closing mid-market price on 21 February 2020, being the latest practicable date before this Announcement."
pugugly: Management yet again blind-sided - As same top man as NANO what are the chances that this is systemic and PHC may go the same way?
ntbb: Buster that makes phc even more valuable, this is ripe for m&a
ntbb: Even with the last rns, phc has fantastic future Highlights: -     Plant Health Care has signed an agreement with Wilbur-Ellis, one of the largest U.S. agriculture distributors, for distribution of Harpin aß (Employ) in the U.S. -     Wilbur-Ellis will market Employ into the specialty crops market, which is estimated to be over 7 million acres in the U.S.   Wilbur-Ellis, a recognized leader in precision agriculture technology and the marketing and distribution of plant protection, seed and nutritional products in the US market, has agreed to be the exclusive distributor for Employ, containing Plant Health Care's Harpin aß technology, for applications to specialty crops (fruits and vegetables) in the U.S. Specialty crops comprise more than 7 million acres in the U.S.   Harpin aß works by triggering the plant's own self defense systems, in a manner similar to vaccinations in humans. The plant responds with improved vigor, healthy growth, heightened defense response and, ultimately, increased yield. Being a biological product, Harpin aß has a very favorable human and environmental safety profile.   Employ provides benefits for the growers of fruits and vegetables through increased yield and quality.  Employ was recognized as Best New Biological Product at the Agrow Awards in November 2018. This new agreement with Wilbur-Ellis will substantially increase the number of growers introduced to the product.   Jesse Rosales, Wilbur-Ellis Branded Technologies Portfolio Manager commented:   "The addition of Employ to our branded offerings is a meaningful step forward to becoming a distribution market leader in the biological solutions space. We are very excited about growing this product in key specialty crops regions like Washington, Oregon, Michigan and the broader Northeastern U.S."  
riddlerone: Yes I am sure you are right.I unfortunately have a similar scenario with MLVN where the CF sale again trashed the share price.Unlike Scancell they have not recovered and may take another year to do so.
Plant Health Care share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Plant Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201127 06:11:28